The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)


Arterial healing following primary PCI using the Absorb everolimus-eluting bioresorbable vascular scaffold (Absorb BVS) versus the durable polymer everolimus-eluting metallic stent (XIENCE) in patients with acute ST-elevation myocardial infarction: rationale and design of the randomised TROFI II study

EuroIntervention 2016;12:482-489 published online ahead of print August 2015. DOI: 10.4244/EIJY15M08_03

1. Bern University Hospital, Bern, Switzerland; 2. Cardialysis B.V., Rotterdam, The Netherlands; 3. Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands; 4. Barcelona University Hospital, Barcelona, Spain; 5. Meixoeiro Hospital, Vigo, Spain; 6

Aims: The Absorb bioresorbable vascular scaffold (Absorb BVS) provides similar clinical outcomes compared with a durable polymer-based everolimus-eluting metallic stent (EES) in stable co

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from

Read next article
Effect of resting heart rate on two-year clinical outcomes of high-risk patients with severe symptomatic aortic stenosis undergoing transcatheter aortic valve implantation